<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35320153</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1530-0315</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
              <Day>22</Day>
            </PubDate>
          </JournalIssue>
          <Title>Medicine and science in sports and exercise</Title>
          <ISOAbbreviation>Med Sci Sports Exerc</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Long-term Exercise Intervention in Patients with McArdle Disease: Clinical and Aerobic Fitness Benefits.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1249/MSS.0000000000002915</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The long-term effects of exercise in patients with McArdle disease-the paradigm of 'exercise intolerance'-are unknown. This is an important question as the severity of the disease frequently increases with time.</AbstractText>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To study the effects of a long-term exercise intervention on clinical and fitness-related outcomes in McArdle patients.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Seventeen patients (exercise group: N = 10, 6 male, 38 ± 18 yrs; control: N = 7, 4 male, 38 ± 18 yrs) participated in a two-year unsupervised intervention including moderate-intensity aerobic (cycle-ergometer exercise for 1 h) and resistance (high load-low repetition circuit) training on 5 and 2-3 days/week, respectively. Patients were assessed at baseline and postintervention. Besides safety, outcomes included clinical severity (e.g., exercise intolerance features) on a 0-3 scale (primary outcome), and aerobic fitness, gross muscle efficiency, and body composition (total/regional fat, muscle, and bone mass) (secondary outcomes).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The exercise program was safe and resulted in a reduction of one point (-1.0, 95% confidence interval -1.6--0.5, p = 0.025) in clinical severity vs. the control group, with 60% of participants in the exercise group becoming virtually asymptomatic and with no functional limitation in daily life activities. Compared with controls, the intervention induced significant and large benefits (all p &lt; 0.05) in the workload eliciting the ventilatory threshold (both in absolute (watts, +37%) and relative units (watts·kg-1 of total body mass or of lower-limb muscle mass, +44%)), peak oxygen uptake (ml·kg-1·min-1, +28%) and peak workload (absolute (+27%) and relative units (+33%)). However, no significant changes were found for muscle efficiency nor for any measure of body composition.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A two-year unsupervised intervention including aerobic and resistance exercise is safe and induces major benefits in the clinical course and aerobic fitness of patients with McArdle disease.</AbstractText>
          <CopyrightInformation>Copyright © 2022 by the American College of Sports Medicine.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Santalla</LastName>
            <ForeName>Alfredo</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Valenzuela</LastName>
            <ForeName>Pedro L</ForeName>
            <Initials>PL</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodriguez-Lopez</LastName>
            <ForeName>Carlos</ForeName>
            <Initials>C</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodríguez-Gómez</LastName>
            <ForeName>Irene</ForeName>
            <Initials>I</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nogales-Gadea</LastName>
            <ForeName>Gisela</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Neuromuscular and Neuropediatric Research Group, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Campus Can Ruti, Universitat Autònoma de Barcelona, Badalona, SPAIN.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pinós</LastName>
            <ForeName>Tomàs</ForeName>
            <Initials>T</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arenas</LastName>
            <ForeName>Joaquín</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martín</LastName>
            <ForeName>Miguel A</ForeName>
            <Initials>MA</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Santos-Lozano</LastName>
            <ForeName>Alejandro</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Morán</LastName>
            <ForeName>María</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fiuza-Luces</LastName>
            <ForeName>Carmen</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigación Sanitaria Hospital '12 de Octubre' ('imas12'), Madrid, SPAIN.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ara</LastName>
            <ForeName>Ignacio</ForeName>
            <Initials>I</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lucia</LastName>
            <ForeName>Alejandro</ForeName>
            <Initials>A</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Med Sci Sports Exerc</MedlineTA>
        <NlmUniqueID>8005433</NlmUniqueID>
        <ISSNLinking>0195-9131</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CoiStatement>Conflict of Interest and Funding Source: Pedro L. Valenzuela is supported by a Sara Borrell postdoctoral contract granted by Instituto de Salud Carlos III (CD21/00138). Gisela Nogales-Gadea and Carmen Fiuza-Luces are supported by a Miguel Servet contract granted by Instituto de Salud Carlos III (ISCIII CPII19/00021 and CP18/00034, respectively). Research by Alejandro Lucia, Carmen Fiuza-Luces, Tomàs Pinós and Joaquín Arenas is supported by grants from Spanish Ministry of Economy and Competitiveness and Fondos FEDER (Fondo de Investigaciones Sanitarias [FIS], grant numbers #PI18/00139, #PI20/00645, PI19/01313, and PI17/02052, respectively). Research by Ignacio Ara and Carlos Rodríguez López group is funded by Biomedical Research Networking Center on Frailty and Healthy Aging (CIBERFES, CB16/10/00314 and CB16/10/00477). Irene Rodríguez-Gómez is supported by a postdoctoral contract from Universidad de Castilla-La Mancha (“Contratos de investigadores postdoctorales para la excelencia científica en el desarrollo del Plan Propio de I+D+i, cofinanciada por el Fondo Social Europeo” (2021/5937)). The authors declare no conflicts of interest. The results of the present study do not constitute endorsement by ACSM, and are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>23</Day>
          <Hour>17</Hour>
          <Minute>15</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35320153</ArticleId>
        <ArticleId IdType="doi">10.1249/MSS.0000000000002915</ArticleId>
        <ArticleId IdType="pii">00005768-990000000-00005</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
